Tag results:

cell transplantation

Exploiting Natural Killer Cell Engagers to Control Pediatric B Cell Precursor Acute Lymphoblastic Leukemia

[Cancer Immunology Research] Investigators tested the in vitro effect of different NK cell engagers, which triggered either NKp46 or NKp30 together with CD16A, and target either CD19 or CD20 to induce killing of pediatric B cell precursor acute lymphoblastic leukemia.

Relationship between Donor-Specific HPA-15 Antibodies and Poor Graft Function in HPA-15 Mismatched Cord Blood Transplantation

[International Journal of Hematology] Investigators encountered a case of human platelet antigen 15 (HPA-15) mismatched cord blood transplantation with a high HPA-15b antibody titer. Prolonged poor graft function and megakaryocyte aplasia with sustained high-titer HPA-15b antibodies were attenuated by rituximab therapy, and rapid recovery of hematopoiesis was achieved.

SUPT4H1-Edited Stem Cell Therapy Rescues Neuronal Dysfunction in a Mouse Model for Huntington’s Disease

[NPJ Regenerative Medicine] Transplanting SUPT4H1-edited Huntington’s disease (HD)-induced pluripotent stem cell-derived neural precursor cells (iPSC-NPCs) into the YAC128 HD transgenic mouse model improved motor function compared to unedited HD iPSC-NPCs.

Mesenchymal Stem Cell–Based Therapy as a New Approach for the Treatment of Systemic Sclerosis

[Clinical Reviews in Allergy & Immunology] The authors overview the current knowledge regarding the therapeutic efficacy of MSCs in systemic sclerosis (SSc), focusing on progresses reported in preclinical and clinical studies using MSCs, as well as challenges and future directions of MSC transplantation as a treatment option for patients with SSc.

Clinical Outcomes of Individualized Busulfan-Dosing in Hematopoietic Stem Cell Transplantation in Chinese Children Undergoing with Therapeutic Drug Monitoring

[Bone Marrow Transplantation] Therapeutic drug monitoring and individualization of busulfan dosage were essential to improve the efficacy and safety of busulfan-based regimen in Chinese pediatric hematopoietic stem cell transplantation recipients.

The Association of Graft-Versus-Leukemia Effect and Graft-Versus Host Disease in Haploidentical Transplantation with Post-Transplant Cyclophosphamide for AML

[Bone Marrow Transplantation] Investigators used a series of landmark analyses to investigate the association of of graft-versus-host disease in the setting of haploidentical SCT (haploSCT) with post-transplant cyclophosphamide in 805 acute myeloid leukemia patients following haploSCT.

Popular